Endoscopic diagnosis and management of peptic ulcer bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2026.

Key Takeaways for GI Nurses

• Video capsule endoscopy and telemetric blood-sensing capsules are not recommended for routine triage of suspected upper GI hemorrhage (UGIH) — nurses should not expect these technologies to replace standard pre-endoscopy assessment protocols in most units.
• Pre-endoscopy prokinetic use is evolving: if IV erythromycin is unavailable, IV metoclopramide may be used in select patients with clinically severe or active bleeding to improve mucosal visualization before scoping. Nurses administering pre-procedure medications should be familiar with both agents' indications and monitoring requirements.
• High-dose IV PPI therapy pre-endoscopy is a "suggested" option, not a requirement — and critically, it should never delay timely endoscopy. Nursing teams coordinating care pathways should ensure PPI infusion setup does not become a bottleneck to scheduling.
• The guideline moves away from mandating ultra-early (≤6h) or urgent (≤12h) scoping for all UGIH patients — timing should be individualized, reserved for hemodynamically unstable patients unresponsive to resuscitation, which has implications for staffing, on-call scheduling, and triage decision-making.

Clinical Relevance

This 2026 update refines several practical aspects of peptic ulcer bleeding management that directly affect day-to-day endoscopy unit workflow. The de-emphasis on emergent or urgent endoscopy timing (unless the patient is hemodynamically unstable despite resuscitation) is particularly significant for nursing triage and resource allocation. Rather than mobilizing after-hours endoscopy teams reflexively for every suspected UGIH case, units can now align scheduling more closely with clinical stability, potentially reducing unnecessary off-hours procedures while still prioritizing genuinely unstable patients. This requires close nursing collaboration with emergency department and gastroenterology teams to accurately assess and communicate hemodynamic status.

The nuanced guidance on pre-endoscopy pharmacologic optimization — prokinetics and PPI therapy — also has direct nursing implications. Nurses are often responsible for initiating and monitoring IV medications prior to endoscopy, and understanding the rationale (e.g., improving gastric visualization by clearing blood and clots, or reducing ulcer-related stigmata before scope insertion) helps nurses anticipate procedural needs and counsel patients and families appropriately. The explicit caveat that PPI administration should not delay endoscopy reinforces the importance of efficient pre-procedure logistics; nurses coordinating care must balance medication administration with timely scope availability.

Finally, the endoscopic management recommendation regarding Forrest IIb (adherent clot) ulcers reinforces the active nursing role during therapeutic endoscopy — assisting with clot removal techniques and subsequent hemostasis (thermal, mechanical, or injection therapy). Nurses assisting in these procedures should stay current on hemostatic device setup, troubleshooting, and appropriate documentation of Forrest classification findings, as this directly informs post-procedure monitoring intensity and rebleeding risk stratification.

Bottom Line

For busy GI nurses, this guideline update signals a shift toward more individualized, judicious use of resources in UGIH management — reserving urgent/emergent endoscopy for truly unstable patients, using pre-endoscopy medications (PPIs, prokinetics) as adjuncts rather than automatic protocols, and maintaining hands-on readiness for active endoscopic hemostasis in ulcers with adherent clots — all while ensuring these interventions never delay the timely endoscopy that remains central to good outcomes.